Drug · DIN 00627100
DILAUDID
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 5, 2023; first marketed December 31, 1984.
- Drug Identification Number (DIN)
- 00627100
- Company (DIN owner)
- Purdue PharmaToronto, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Liquid
- Route
- Subcutaneous; Intravenous; Intramuscular
- Therapeutic class (ATC)
- Hydromorphone N02AA03
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE | 2 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 8, 2008: NOC 9710New Drug Submission (NDS) · Manufacturer name change
- July 19, 2001: NOC 2309New Drug Submission (NDS) · Change in manufacturer's name
Other DINs named DILAUDID
- DIN 00125083 · Marketed
- DIN 00125121 · Marketed
- DIN 00705438 · Marketed
- DIN 00786543 · Marketed
- DIN 00125105 · Cancelled Post Market
- DIN 00786535 · Cancelled Post Market
- DIN 02085895 · Cancelled Post Market